Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2007-003254-28-IT
EUCTR2007-003254-28-IT
Active, not recruiting
Not Applicable

RADIOCHEMIOTERAPIA CON TEMOZOLOMIDE CONCOMITANTE E ADIUVANTE NEL TRATTAMENTO DEI LINFOMI CEREBRALI PRIMITIVI DOPO METOTREXATE AD ALTE DOSI: STUDIO DI DOSE ESCALATION - ND

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 sitesApril 9, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsprimary central nervous lymphomaMedDRA version: 9.1Level: HLGTClassification code 10025323Term: Lymphomas NEC
DrugsTEMODAL

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
primary central nervous lymphoma
Sponsor
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 9, 2008
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Eligibility Criteria

Inclusion Criteria

  • •histologic diagnosis of PCNSL
  • •Exclusive localization of intracranial disease
  • •written informed consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •organ failure

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Temozolomide in Concomitant Radiochemotherapy Followed by Sequential Temozolomide Chemotherapy - Observational Program (Study P04816)Glioblastoma
NCT00725010Merck Sharp & Dohme LLC64
Completed
Phase 3
Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeBrain and Central Nervous System Tumors
NCT00006353European Organisation for Research and Treatment of Cancer - EORTC575
Active, not recruiting
Not Applicable
Chimiothérapie par Témozolomide dans le traitement des glioblastomes supratentoriels des sujets de 70 ans et plus présentant un état fonctionnel altéré (IK<70). - TAGPatients de 70 ans et plus atteints de glioblastomes supratentoriels et présentant un état fonctionnel altéré.MedDRA version: 8.1Level: PTClassification code 10018336Term: glioblastome
EUCTR2006-005549-12-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
Active, not recruiting
Phase 1
TEMOZOLOMIDE + ULTRA-HYPER-FRACTIONATED RADIOTHERAPY VS TEMOZOLOMIDE ALONE FOR THE MAINTENANCE TREATMENT OF GLIOBLASTOMA PATIENTS - PILOT STUDYhistologically confirmed glioblastoma according to WHO criteria (grade IV).MedDRA version: 20.0Level: PTClassification code 10018336Term: GlioblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2021-003275-34-ITIRCCS-A.O.U. SAN MARTINO-IST30
Unknown
Phase 2
The Effect of Chemoradiotherapy in Patients With Refractory Pituitary AdenomasPituitary Adenomas
NCT04244708Peking Union Medical College Hospital150